Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

unknown1
Not yet recruiting1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown125%
not_yet_recruiting125%
active_not_recruiting125%
recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Ablation of Fibrotic Areas in Patients With Persistent Atrial Fibrillation.

NCT04377594
not_yet_recruitingnot_applicable

A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study)

NCT06098989
recruitingnot_applicable

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

NCT05243082
unknown

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION

NCT05320328

Clinical Trials (4)

Showing 4 of 4 trials
NCT04377594Not Applicable

Ablation of Fibrotic Areas in Patients With Persistent Atrial Fibrillation.

Active Not Recruiting
NCT06098989Not Applicable

A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study)

Not Yet Recruiting
NCT05243082Not Applicable

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

Recruiting
NCT05320328

RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4